2021 CMSC Annual Meeting

Tag: VA

Poster-Disease-modifying Therapy

Analysis of Health Care Provider Reasons for Switching to Diroximel Fumarate from Other Disease-Modifying Therapies

Background: Switching of disease-modifying therapies (DMTs) for treatment of multiple sclerosis (MS) is driven by many factors that are not...

Read More

Platform-Psychosocial

Social-Cognitive Correlates of Physical Activity in Fatigued and Non-Fatigued Persons with Multiple Sclerosis

Background: There is interest in the application of behavioral interventions for increasing physical activity among adults with multiple...

Read More

Platform-Psychosocial

The Art of the Patient Conversation: Advanced Practice Provider Perspectives to Improve Outcomes in Multiple Sclerosis

Background: Robust health literacy, defined by the Centers for Disease Control and Prevention as the degree to which an individual …...

Read More